Sign in

CIK 0001818794 · Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
364883909
Phone
(781) 786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
  1. 4 Planned sale SVP, Head of Finance & Admin. sold 1,468 shares at $31.89 ($46,815)
  2. 4 Planned sale Chief Operating Officer sold 5,270 shares at $31.89 ($168,060)
  3. 4 Open-market sale SVP, Head of Finance & Admin. sold 126,074 shares at an average $32.15 ($4,052,851)
  4. 4 Planned sale Director sold 1,577 shares at $35.03 ($55,242)
  5. 144 Insider Sale of Securities
  6. 144 Insider Sale of Securities
  7. 4 Open-market buy CEO & President bought 32,000 shares at an average $33.04 ($1,057,216)
  8. 4 Planned sale Director sold 31,300 shares at an average $45.59 ($1,427,063)
  9. 4 Grant or award Chief Medical Officer acquired 47,500 shares (grant or award)
  10. 3 Insider Initial Statement of Ownership
  11. 4 Grant or award Chief Commercial Officer acquired 58,400 shares (grant or award)
  12. 3 Insider Initial Statement of Ownership
  13. 8-K Event Executive or director change · Regulation FD disclosure · Other events
  14. 4 Planned sale Director sold 134,261 shares at an average $45.03 ($6,045,783)
  15. 4 Planned sale Director sold 154,900 shares at an average $44.87 ($6,950,453)
  16. 4 Planned sale Director sold 180,409 shares at an average $46.02 ($8,302,088)
  17. 4 Planned sale Director sold 222,603 shares at an average $46.61 ($10,375,620)
  18. 144 Insider Sale of Securities
  19. 4 Planned sale SVP, Head of Finance & Admin. sold 2,752 shares at an average $45.12 ($124,174)
  20. 4 Planned sale Chief Business Officer sold 2,705 shares at an average $45.12 ($122,054)

Page 18 of 40 · 796 filings